The Dividend Stocks That Generate $60,000 Tax-Free Inside a Roth (And What They Cost You in a Taxable Account)24/7 Wall Street • 05/23/26
AbbVie Announces Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) for the Treatment of Acute Hepatitis C InfectionPRNewsWire • 05/22/26
The Dividend Stocks That Can Replace a $65,000 Income and What They'll Cost You24/7 Wall Street • 05/22/26
AbbVie Announces New Data at ASCO 2026 Demonstrating Breadth and Momentum Across its Next-Generation Oncology PipelinePRNewsWire • 05/21/26
Allergan Aesthetics Receives Positive CHMP Opinion for Boey® (TrenibotulinumtoxinE) for the Temporary Improvement of Moderate to Severe Glabellar Lines in AdultsPRNewsWire • 05/21/26
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending StockZacks Investment Research • 05/19/26
Realty Income Has Raised Its Dividend 113 Consecutive Times. Here Is Why That Is Not Enough to Own It Right Now24/7 Wall Street • 05/15/26
AbbVie Inc. (ABBV) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/14/26
The Zacks Analyst Blog NVIDIA, Mastercard, AbbVie, Waterstone and PrecipioZacks Investment Research • 05/13/26
A Tiny Biotech Just Beat AbbVie's $17 Billion Drug. Should Investors Be Worried?The Motley Fool • 05/11/26
6 Pharma Dividend Stocks Yielding Up to 6.44% — and They've Survived Every Market Crash24/7 Wall Street • 05/06/26
AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel Diseases (IBD) at 2026 Digestive Disease Week®PRNewsWire • 05/05/26